Sign In   Register

Cannabis and Hemp Industry Investment News

Cannabis Industry Press Releases and News Articles from the best investment journalist in the industry. Stay updated on all cannabis investment news from every online source, on MjInvest.com

Monarch Life Sciences - 2022 Press Release (Updated April 2022)

4 minutes reading time (884 words)

For Immediate Release:

FIRST OF THEIR KIND, REMEDY-SPECIFIC, CANNABINOID AEROSOLS SHOWN TO BE 4-5 TIMES MORE EFFECTIVE WITH GREATER ABSORPTION THAN TRADITIONAL OIL TINCTURES

Nano Mist CBD Aerosols containing unprecedented bio-active terpene blends provide targeted, controlled sensory effects to aid sleep, anxiety, pain management and appetite control.

Monarch Life Sciences LLC, (dba MonarchRemedy.com), is pleased to offer a line of receptor specific sublingual tincture aerosols, including the addition of beneficial cannabinoids and bio-active, effect-based terpenes. The sublingual aerosols include five primary terpene enhanced formulations – MOOD LIFT, PEACE OUT, RELIEF RESCUE, M.E.L.T. and DEEP ZZZ'S. Each sublingual aerosol contains 2000mg of full-spectrum CBD, a water soluble micellized CBD, bio-active terpenes, herbs, botanicals, and other essential cannabinoids delivering 200+ sprays at 10.0mg of cannabinoids per actuation use.

"The world of CBD is evolving, becoming more sophisticated. As it matures, consumers are creating a demand for premium wellness products with effect driven formulations requiring accurate dosing while being discreet, easy to use and more affordable," said James Matuszewski, Co-Founder of Monarch. "Monarch is not shy about going head-to-head with current antiquated, low-dose gummies, high-cost edibles, beverages, and traditional oil-dropper tincture delivery systems. Our ability to provide consumers with an effect-driven product, at a higher cannabinoid content, and quicker onset at a lower cost per use, provides a key advantage in the global CBD marketplace."

Utilizing proprietary cannabinoid-based formulations (e.g., CBD, CBG, CBN, THCv), in combination with customized receptor terpene compounds, Monarch is offering the most advanced sublingual formulations and aerosol delivery systems available today. The breakthrough of utilizing specific effect-based terpenes during formulations has completely changed the approach in presenting products to the consumer. Monarch can now dial in to certain ailments or issues that directly speak to the end user as to how they want to address various conditions and get the results they expect, quicker and more effectively. Monarch's proprietary CBD aerosol delivery systems also have the highest net absorption rates at upwards of 85%, compared to traditional oil tinctures that have a net absorption of rate of 10%-20%*.

In addition to offering innovative aerosols, Monarch is focused on the overall quality-to-value of its products to consumers. Despite CBD's rise in popularity, much of it has just become cost-prohibitive for many consumers to afford on a daily-use basis. "We've developed advanced formulations with additional cannabinoids like CBG, CBN and water-soluble Hempzorb81, a robust full-spectrum hemp oil that is the most absorptive cannabinoids compound on the market. Together with development of exclusive custom terpene compounds, our aerosols deliver truly targeted, remedy specific results. We want our customers to experience the full benefits of our products for an array of daily needs or ailments," states Matuszewski. New studies and advancements in cannabinoid research support higher dosage amounts** of CBD to achieve the desired effects and benefits of daily use. However, higher dosing and daily use impedes the affordability for most users wanting to achieve a higher level of noticeable results.

Monarch has arranged a manufacturing partnership with Colorado based R2 Innovations, Inc., to develop and offer advanced aerosol delivery systems. R2 Innovations has been the leader in aerosol manufacturing, research and development, and a proprietary water-soluble cannabis technology since 2015. They continue to provide new aerosol technology developments to the cannabis industry in the US and globally.

Offering the most advanced formulations available, Monarch uses a proprietary, patent pending, water-soluble micelle technology, Hempzorb81, supported by NIH clinical trials for safety, efficacy, and bioavailability. Hempzorb81 delivers an unmatched bioavailability (absorption) of 85% and the most rapid onset of action on the market at 15 minutes, making it the most effective CBD or full spectrum hemp oil available. Micellization is a process that produces tiny droplets (micelles) that are then formed into highly absorbable compounds, delivering true, water-soluble, full-spectrum cannabinoids with a quicker-onset and greater bioavailability. This, combined with highly specialized formulations creates a superior aerosol product for convenient, accurate administration.Monarch's daily use aerosols are available direct to consumers online via e-commerce at MonarchRemedy.com Monarch ships throughout the United States and all orders $40 or more ship free. Monarch offers a 20% military and First Responders discount to active or retired service members and their families. Visit Monarch online or email for more information at info@MonarchMeds.com.


*Source: Extract Labs, 'CBD Bioavailability', October 2020.**Source: FORBES Health, 'CBD Dosage', August 2021

About Monarch Life Sciences
Monarch Life Sciences, LLC ("MLS") was established in 2018 as a Colorado Limited Liability Company. MLS provides consumer direct initiatives for proprietary cannabinoid ("CBD") products, formulations, and advanced aerosol technologies along with key niche CBD offerings. Monarch's products are formulated and manufactured in Centennial, Colorado USA. MonarchRemedy.com Social: @MonarchRemedy

About R2 Innovations Incorporated

Established in 1998 R2 Innovations Incorporated, a leader in cannabinoid derived aerosol technology, creates, formulates and manufactures innovative consumer facing products for the sports, active lifestyle and legal medical and recreational cannabis industries world-wide. R2 owns the exclusive global rights to a proprietary, water soluble, micelle technology known as Purzorb® / Hempzorb 81™. R2 is positioned to deliver high potency, full and broad-spectrum CBD and THC products utilizing this technology. R2's aerosol formulation technology and processes deliver a truly differentiated offering to its customers, elevating their customers and client's brands in the global marketplace. R2Innovations.com

# # # 

MEDIA CONTACT James Matuszewski Monarch Life Sciences, LLC

Direct: 720.788.9719

james@monarchmeds.com


Related Posts


MjInvest.com